March 12, 2026

Dupilumab Faces Trial in Chronic Hives

Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.

Conexiant

March 12, 2026

Childhood Oral Health Linked to Adult Cardiovascular Risk

Study links childhood dental disease with higher incidence of ischemic heart disease, myocardial infarction, and ischemic stroke in adulthood.

Conexiant

March 12, 2026

Precision Therapies: The Last Mile

Why therapies still take years to reach the patients who need them

The Medicine Maker

March 12, 2026

ACP Calls for Sweeping Policy Shifts on Disability in Medicine

Twin policy statements in Annals of Internal Medicine outline structural reforms aimed at improving health care access for patients with disabilities and supporting physicians with disabilities in training and practice.

Conexiant

March 12, 2026

The 60 Percent Diagnostic Gap in M/E

What earlier mNGS testing could mean for labs and clinicians

The Pathologist

March 11, 2026

Sudden Vision Loss: Could It Be Pituitary Apoplexy?

Case report highlights delayed treatment and persistent visual loss in a patient with pituitary adenoma

Conexiant

March 10, 2026

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

Conexiant

March 06, 2026

Are AI Models Cheating in Biomarker Predictions?

Study finds image-based predictions often reflect confounding factors rather than true molecular signals

The Pathologist

March 05, 2026

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Conexiant

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant